Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22485048 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults
Condition: Meningococcal Infection
Interventions: Biological: Meningococcal vaccine GSK134612;   Biological: Mencevax™ACWY;   Biological: Fluarix™

Indicates status has not been verified in more than two years